Apple News In Conversation cover image

Why a 25-cent pill is being sold to cancer patients for nearly $1,000

Apple News In Conversation

00:00

The High Cost of Life-Saving Medications

This chapter examines the shocking disparity between the manufacturing cost and the selling price of Revlimid, a cancer medication. Through personal anecdotes, it highlights the financial struggles faced by patients and the broader implications on healthcare costs for everyone.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app